Vibrio Vulnificus O-Antigen Disaccharide Synthesis for Structural Purity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The chemical synthesis of the disaccharide fragment of V. vulnificus biotype 2 serovar A O-antigen is challenging due to the presence of rare L-aminogalacturonic acid, 1,2-cis glycosidic bonds, and acetamidino group modifications, which affect synthesis efficiency and purity, limiting the development of effective vaccines.
Innovation Solution
A chemical synthesis method is developed using specific monosaccharide building blocks and linkers with varying protecting groups, followed by a series of reactions to assemble a disaccharide fragment with a linker, optimizing glycosylation and deprotection steps to achieve high purity and efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If biological pathways are used to obtain O-antigen, then the O-antigen can be obtained, but structural heterogeneity and residual impurities reduce safety and efficacy
Solution Approach 1:
The patent replaces biological production pathways with chemical synthesis methods to produce O-antigen. This substitution eliminates the structural heterogeneity and residual impurities (such as lipid A and cellular impurities) inherent in biological production, while maintaining the desired structural specificity and functional properties of the O-antigen for vaccine development.
2Manufacturing precision
If chemical synthesis is used to prepare oligosaccharides, then high purity and single structure can be obtained, but the synthesis process is complex and challenging
Solution Approach 1:
The patent divides the complex O-antigen synthesis into modular steps using protected monosaccharide building blocks. The synthesis route is segmented into discrete glycosylation reactions with specific protecting groups (PG1-PG7) that can be systematically managed and optimized, transforming the complex overall process into manageable sequential steps.
Solution Approach 2:
The patent employs protecting groups (PG1-PG7) as intermediary elements that temporarily modify specific hydroxyl groups during synthesis. These protecting groups act as mediators that enable selective reactions at specific positions while blocking others, allowing complex multi-step syntheses to proceed with high precision and control.
3Manufacturing precision
If rare L-aminogalacturonic acid and 1,2-cis glycosidic bonds are synthesized, then the specific O-antigen structure is achieved, but synthesis efficiency decreases
Solution Approach 1:
The patent employs preliminary action by using pre-configured monosaccharide building blocks with protected hydroxyl groups and pre-formed glycosidic bonds. The rare L-aminogalacturonic acid and 1,2-cis glycosidic bonds are incorporated in advance during the assembly of building blocks, so that when the final synthesis occurs, the complex structural features are already in place, reducing the efficiency penalty.
Solution Approach 2:
The patent utilizes parameter changes by employing different protecting groups (PG1-PG7) with varying reactivity and stability characteristics. By carefully selecting and changing protecting group parameters during different synthesis stages, the process optimizes the formation of rare structures like L-aminogalacturonic acid and 1,2-cis glycosidic bonds while maintaining overall synthesis efficiency.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method enhances the synthesis yield of the disaccharide fragment, improving its potential as a target for immune responses and facilitating the development of saccharide vaccines.
Implementation Method 1
reaction A (glycosidation reaction): enabling the monosaccharide building block 1 to experience a glycosidation reaction with the linker 3
Implementation Method 2
reaction G (reduction of azido group to amino group)
Implementation Method 3
reaction E (oxidization of primary hydroxyl group to carboxyl group)
Implementation Method 4
reaction C (deprotection on position 3 in quinovosamine): after completing the reduction and acetylation of the azido group, performing deprotection on position 3 to remove the protecting group PG1
Data Source
AI summary
The disclosure provides a chemical synthesis method for a disaccharide fragment of a Vibrio vulnificus biotype 2 serovar A O-antigen, belonging to the chemical field. The disclosure utilizes D-glucose and L-galactose as raw materials to prepare two types of glycosylated building blocks, and designs an efficient synthesis route for constructing the disaccharide fragment. By optimizing protecting groups and optimizing the time of introducing modifying groups, the preparation of the target disaccharide is successfully completed. The raw materials for preparing the disaccharide in the disclosure are readily available, the preparation method is simple and easy to repeat, and will have a good application prospect in the development of new drugs and vaccines for V. vulnificus.